Abiraterone acetate: oral androgen biosynthesis inhibitor for treatment of castration-resistant prostate cancer

by Rehman, Yasser, Rosenberg, Jonathan E
Published 2012

The emerging role of antibody-drug conjugates in urothelial carcinoma

by Lattanzi, Michael, Rosenberg, Jonathan E
Published in Expert Rev Anticancer Ther (2020)

Advanced Urothelial Carcinoma: Overcoming Treatment Resistance through Novel Treatment Approaches

by Bambury, Richard M., Rosenberg, Jonathan E.
Published 2013

Systemic, perioperative management of muscle-invasive bladder cancer and future horizons

by Funt, Samuel A., Rosenberg, Jonathan E.
Published in Nat Rev Clin Oncol (2016)

Targeting nectin-4 by antibody-drug conjugates for the treatment of urothelial carcinoma

by Wong, Jeffrey L., Rosenberg, Jonathan E.
Published in Expert Opin Biol Ther (2021)

Novel agents for advanced bladder cancer

by Sonpavde, Guru, Elfiky, Aymen A., Rosenberg, Jonathan E.
Published 2009

Personalized therapy for urothelial cancer: review of the clinical evidence

by Guancial, Elizabeth A., Chowdhury, Dipanjan, Rosenberg, Jonathan E.
Published 2011

Developing precision medicine for bladder cancer

by Guercio, Brendan J., Iyer, Gopa, Rosenberg, Jonathan E.
Published in Hematol Oncol Clin North Am (2021)

Update in Urothelial Carcinoma: Novel Agents and Targeted Therapy

by Guancial, Elizabeth A., Rosenberg, Jonathan E., Sweeney, Christopher J.
Published in Am Soc Clin Oncol Educ Book (2011)

Novel molecular targets for urothelial carcinoma

by Faltas, Bishoy M., Karir, Beerinder S., Tagawa, Scott T., Rosenberg, Jonathan E.
Published in Expert Opin Ther Targets (2015)

Elevating the Horizon: Emerging Molecular and Genomic Targets in the Treatment of Advanced Urothelial Carcinoma

by Kurtoglu, Metin, Davarpanah, Nicole N., Qin, Rui, Powles, Thomas, Rosenberg, Jonathan E., Apolo, Andrea B.
Published in Clin Genitourin Cancer (2015)

Urothelial carcinoma: Stem cells on the edge

by Brandt, William D., Matsui, William, Rosenberg, Jonathan E., He, Xiaobing, Ling, Shizhang, Schaeffer, Edward M., Berman, David M.
Published 2009

The Cancer Immunogram as a Framework for Personalized Immunotherapy in Urothelial Cancer

by van Dijk, Nick, Funt, Samuel A., Blank, Christian U., Powles, Thomas, Rosenberg, Jonathan E., van der Heijden, Michiel S.
Published in Eur Urol (2018)

Treatment Decision Making in Patients with Bladder Cancer

by Berry, Donna L., Nayak, Manan, Halpenny, Barbara, Harrington, Shannon, Loughlin, Kevin R., Chang, Peter, Rosenberg, Jonathan E., Kibel, Adam S.
Published in Bl Cancer (2015)

Clinical Validation of Chemotherapy Response Biomarker ERCC2 in Muscle-invasive Urothelial Bladder Carcinoma

by Liu, David, Plimack, Elizabeth R., Hoffman-Censits, Jean, Garraway, Levi A., Bellmunt, Joaquim, Van Allen, Eliezer, Rosenberg, Jonathan E.
Published in JAMA Oncol (2016)

Combination of a novel gene expression signature with a clinical nomogram improves the prediction of survival in high-risk bladder cancer

by Riester, Markus, Taylor, Jennifer M., Feifer, Andrew, Koppie, Theresa, Rosenberg, Jonathan E., Downey, Robert J., Bochner, Bernard H., Michor, Franziska
Published 2012

The High Incidence of Vascular Thromboembolic Events in Advanced Urothelial Cancer Treated with Platinum Chemotherapy Agents

by Tully, Christopher M., Apolo, Andrea B., Zabor, Emily C., Regazzi, Ashley M., Ostrovnaya, Irina, Rosenberg, Jonathan E., Bajorin, Dean F.
Published in Cancer (2015)

Improved 5-factor prognostic classification of patients receiving salvage systemic therapy for advanced urothelial carcinoma

by Sonpavde, Guru, Pond, Gregory R., Rosenberg, Jonathan E., Bajorin, Dean F., Choueiri, Toni K., Necchi, Andrea, Di Lorenzo, Giuseppe, Bellmunt, Joaquim
Published in J Urol (2015)

Docetaxel, bevacizumab, and androgen deprivation therapy for biochemical relapse after definitive local therapy for prostate cancer

by McKay, Rana R., Gray, Kathryn, Hayes, Julia H., Bubley, Glenn, Rosenberg, Jonathan E., Hussain, Arif, Kantoff, Philip W., Taplin, Mary-Ellen
Published in Cancer (2015)

Global Cancer Transcriptome Quantifies Repeat Element Polarization between Immunotherapy Responsive and T Cell Suppressive Classes

by Solovyov, Alexander, Vabret, Nicolas, Arora, Kshitij S., Snyder, Alexandra, Funt, Samuel A., Bajorin, Dean F., Rosenberg, Jonathan E., Bhardwaj, Nina, Ting, David T., Greenbaum, Benjamin D.
Published in Cell Rep (2018)